Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
40,184,918
-
Share change
-
-15,585,735
-
Total reported value
-
$4,136,632
-
Put/Call ratio
-
37%
-
Price per share
-
$0.10
-
Number of holders
-
76
-
Value change
-
-$2,115,841
-
Number of buys
-
32
-
Number of sells
-
36
Institutional Holders of VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) as of Q4 2022
As of 31 Dec 2022,
VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,184,918 shares.
The largest 10 holders included
BlackRock Inc., STATE STREET CORP, GSA CAPITAL PARTNERS LLP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, TWO SIGMA INVESTMENTS, LP, MAI Capital Management, Bank of New York Mellon Corp, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC.
This page lists
76
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.